Halberd

Halberd Long-term Debt

The Long-Term Debt of Halberd (HALB) as of Oct 10, 2026 is 150,000.00 USD. In the previous year, Long-Term Debt was 150,000.00 USD — a change of 0.00% (lower).

Long-term Debt

150,000.00USD

YoY

0.00%

Last updated:

Long-Term Debt of Halberd is 2023 150,000.00 USD. Long-Term Debt of Halberd was 2022 150,000.00 USD. It decreases by 0.00% lower compared to the previous year.

The Halberd Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2022
150,000.00 USD
Jan 1, 2023
150,000.00 USD
The Halberd Long-term Debt history
YEARLong-term DebtYoY
150,000.00USD0.00%
150,000.00USD—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Long-Term Debt of Halberd is 150,000.00 USD in 2023.

Long-Term Debt of Halberd changed from 150,000.00 USD to 150,000.00 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Halberd since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Halberd historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Halberd

All Key Metrics — Halberd